GPTHEALTH GPT Healthcare Q3 FY25 results (Oct–Dec 2024) and concall
GPT Healthcare delivered a resilient Q3 FY25 performance with 6% YoY growth in both revenue and PAT, reaching INR 102 crores and INR 12 crores respectively. The company maintained a 22% EBITDA margin for the nine-month period and significantly reduced finance costs by 55%. Despite external challenges impacting overall FY25 growth, GPT Healthcare is actively expanding its footprint with new hospitals in Raipur and Jamshedpur, while strategically improving ARPOB and operational efficiency through reduced ALOS.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 106 | 102 |
| EBITDA | 23 | 21 |
| Net profit | 15 | 12 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
